Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07239219 · ClinicalTrials.gov registry record · NA
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
A NA study of Urinary Tract Infection and Catheter Infection, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07239219: Recruiting NA study of Urinary Tract Infection and Catheter Infection, sponsored by Ohio State University.
NCT07239219 is a NA study of Urinary Tract Infection and Catheter Infection that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 300 participants, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07239219, a NA study of Urinary Tract Infection and Catheter Infection, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Primary Outcome
Evaluate the rate of urinary tract infection after urethral catheter removal.
Conditions Studied
Interventions
- OTHER 0.05% Chlorhexidine Gluconate
- OTHER Normal Saline
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-12-31 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT07239219 shows while recruiting
NCT07239219 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 646-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (54% lower).
The record links to 3 conditions, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which 0.05% Chlorhexidine Gluconate is the first listed.
NCT07239219 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07239219 about?
NCT07239219 is a clinical study titled "The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.". Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation i...
What is the current status of trial NCT07239219?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-12-31. Estimated completion is 2028-01-01.
What conditions does trial NCT07239219 study?
This clinical trial studies the following conditions: Urinary Tract Infection, Catheter Infection, Antibiotic.
What interventions are being tested in trial NCT07239219?
The interventions under investigation include: 0.05% Chlorhexidine Gluconate (OTHER), Normal Saline (OTHER).
Who is sponsoring clinical trial NCT07239219?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07239219 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07239219's enrollment target sits among peer trials
300 6th of 11 higher than 5 of 11 other Urinary Tract Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
RECRUITING · NA
-
Cefpodoxime vs Ciprofloxacin for Acute Cystitis
COMPLETED · NA
-
Healthy.io Method Comparison & User Performance Study
COMPLETED · NA
-
ParentLink: Better and Safer Emergency Care for Children
COMPLETED
-
Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
COMPLETED · Phase 4
-
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI